Fundamentally improving lives and innovating healthcare with Jeff Aronin

Jeff Aronin has a passionate career for helping others and guiding the medical industry in developing and marketing medicine. Jeff began his career with meeting with a physician who was ultimately making a critical decision for a child. This child was suffering from a seizure disorder, and while the physician made the decision to try to start the child on a medication and sparing the child from surgery. This interaction guided Jeff further into his passion for helping patients that he had his entire career.

 

Jeff began his career in the medical field and also obtained his bachelor’s degree from Northern Illinois University and an MBA from DePaul University. In 2000 Jeff then became the founder and CEO of Ovation Pharmaceuticals LLC. A company in which Jeff created to better fit the unmet needs of patients with rare and neglected diseases. The common goal of Ovation Pharmaceuticals was to address the smaller diseases that patients were facing. In 2009 a Danish healthcare company opted to buy Ovation for $900 million. The company that Jeff started on his own was now a multimillion dollar corporation that continued to help people around the world find a way to cope with their diseases and conditions.

 

Jeff Aronin also is the founder, CEO, and chairman of the Aronin family foundation. This foundation supports patient advocacy and research around the world of rare and overlooked diseases and conditions. Hospitals in Chicago, IL and internationally have benefited from the support from this foundation. With his compassionate heart and success Jeff and his foundation are changing lives around the world.

 

With his leadership skills in organizing research teams who ultimately have the same goals in finding cures for rare and terminal illnesses, Jeff has become a significant role model for business leaders around the world. With the continued support of Jeff and his teams, they will continue to expand the medical field with positive changes for rare and terminal illnesses globally. Jeff continues to expand his knowledge to young entrepreneurs who are also eager to make a change in the healthcare industry and around the world.